Inaktiver Wert

Andere Sprachen Avivagen Inc Other OTC

Aktien

CA05382F1036

Schlusskurs Other OTC Andere Börsenplätze
- ^USD	-

2023	Avivagen Inc. gibt einen neuen 500 kg Auftrag für OxC-beta bekannt	CI
2023	Avivagen Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Juli 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Avivagen Inc. Announces New 500 Kg Order for OxC-beta	17.10.23
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	29.09.23
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta? Livestock Product	24.07.23
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	06.06.23
Avivagen Inc. Announces Significant Increase in Sales to an Existing Customer	25.05.23
Avivagen Announces Review of Strategic Alternatives	18.05.23
Avivagen Inc. Announces Board Changes	19.04.23
Avivagen Narrows Fiscal Q1 Loss, Revenue Falls; Says Will Need Cash Proceeds to Continue as Going Concern	17.03.23
Avivagen Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	17.03.23
Avivagen Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	21.02.23
Avivagen Inc. Auditor Raises 'Going Concern' Doubt	21.02.23
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	16.09.22
Avivagen Reports New Customer in Mexico; Up 8.6%	19.08.22
Avivagen Inc. Secures New Customer in the Mexican Dairy Industry	19.08.22
Avivagen Inc. Announces Receipt of Repeat Order from Asian Customer	11.08.22
Avivagen Inc. Secures Order for OxC-beta from AB Vista	03.08.22
Avivagen Inc. Announces Sales of Companion Animal Product and 6,000 pouches order through new and existing customers in Taiwan and Mexico	29.07.22
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	15.06.22
Avivagen Announces Successful Completion of Formal Safety and Toxicology Evaluation of Fully Oxidized Beta-Carotene	09.06.22
Avivagen Signs New Distribution Partner in Vietnam to Support Southeast Asian Growth	30.05.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Avivagen Inc Other OTC

Aktien

CA05382F1036

Andere Sprachen

Filter